Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04046731 · ClinicalTrials.gov registry record · NA
Neuromuscular Blocking Agents Utilized During Perioperative Hypersensitivity Evaluation
A NA study of Allergy, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 187
- Enrollment target
- 1
- Study location
NCT04046731: Completed NA study of Allergy, sponsored by Mayo Clinic.
NCT04046731 is a NA study of Allergy that has completed, run by Mayo Clinic. The registered enrollment target is 187 participants, below the 320-participant average among 15 other Allergy trials with a reported enrollment target (42% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04046731, a NA study of Allergy, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 187 participants
- Enrollment target
- 1
- Study location
Study Summary
The researchers are trying to develop an allergy skin test to help predict allergic responses to medications commonly given to patients during surgery.
Primary Outcome
Determine the NIC to common NMBAs
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Skin Testing
Study Locations (1)
Florida
- Mayo Clinic - Jacksonville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 187 participants |
| Start Date | 2019-09-20 |
| Est. Completion | 2021-12-31 |
| Phase | NA |
What the finished NCT04046731 record still lists
NCT04046731 is an interventional study that assigns participants to a tested intervention. The registered 187 participants enrollment target is mid-sized for trials with a published cap, below the 320-participant average among 15 other Allergy trials with a reported enrollment target (42% lower).
The record links to 1 condition, with Allergy appearing as the primary indexed condition, and to 1 intervention - of which Skin Testing is the first listed.
NCT04046731 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT04046731 about?
NCT04046731 is a clinical study titled "Neuromuscular Blocking Agents Utilized During Perioperative Hypersensitivity Evaluation". The researchers are trying to develop an allergy skin test to help predict allergic responses to medications commonly given to patients during surgery.
What is the current status of trial NCT04046731?
This trial is currently completed. It is a NA study. The enrollment target is 187 participants. The study started on 2019-09-20. Estimated completion is 2021-12-31.
What conditions does trial NCT04046731 study?
This clinical trial studies the following conditions: Allergy.
What interventions are being tested in trial NCT04046731?
The interventions under investigation include: Skin Testing (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04046731?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04046731 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Allergy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04046731's enrollment target sits among peer trials
187 6th of 15 higher than 10 of 15 other Allergy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Allergy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Understanding Allergies and Sensitizations in Healthy and Allergic Individuals
RECRUITING
-
The Nonirritating Concentrations of Midazolam, Ketamine, and Ondansetron
RECRUITING · Phase 4
-
Safety Study of Viaskin® Peanut Patch in Peanut-Allergic Children 1 Through 3 Years of Age (COMFORT Toddlers)
RECRUITING · Phase 3
-
Childhood Allergy and the Neonatal Environment
ACTIVE NOT RECRUITING
-
Urban Environmental Factors and Childhood Asthma
COMPLETED
-
Omalizumab (Xolair) and Allergy Shots For the Treatment of Seasonal Allergies
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06153251 · 187 participants · Phase 1
A Study to Assess BMS-986453 in Participants With Relapsed and/or Refractory Multiple Myeloma
- NCT06254898 · 187 participants · NA
Use of Incentives for Stressful Medical Procedures
- NCT07062237 · 187 participants · NA
A Randomized Clinical Trial Comparing Embryo Euploidy Rates Following Ultrashort Versus Standard Abstinence
- NCT07217574 · 187 participants
Program in Oncology for Tribal Health Systems.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI